Welcome to Dwaey, specifically on Pheniramine Maleate + Naphazoline HCl Eye prep page.
This medicine contains important and useful components, as it consists of
Pheniramine Maleate + Naphazoline HCl Eye prep is available in the market in concentration.
Pheniramine Maleate + Naphazoline HCl Eye prep
Before starting treatment with Pheniramine Maleate + Naphazoline HCl eye preparation, it is critical for patients to consult their healthcare provider. Certain precautions should be taken to avoid complications:
- Pre-existing Eye Conditions: This combination should be used cautiously in patients with glaucoma, particularly narrow-angle glaucoma, as Naphazoline can potentially increase intraocular pressure.
- Systemic Effects: Both Pheniramine (an antihistamine) and Naphazoline (a decongestant) can have systemic effects, especially if overused. Overuse may lead to hypertension or other cardiovascular issues, and should be avoided.
- Allergies: Patients with a known allergy to any components of the medication, including antihistamines or sympathomimetics, should not use this preparation.
- Pregnancy and Breastfeeding: Pregnant or breastfeeding women should consult their healthcare provider before using this product, as there may be a risk to the baby, although the exact effects are not fully established.
- Contact Lens Wearers: Individuals wearing soft contact lenses should avoid using this eye drop, as Naphazoline may lead to irritation, and the preservative used in the formulation could also cause discomfort.
Pheniramine Maleate + Naphazoline HCl eye preparation is typically used for:
- Allergic Conjunctivitis: The combination is primarily indicated to relieve the symptoms of allergic conjunctivitis, which can include redness, itching, and swelling in the eyes due to allergic reactions. This is often caused by allergens like pollen, dust, or pet dander.
- Eye Irritation: It can also be used to relieve eye irritation caused by environmental factors such as smoke, wind, or exposure to bright lights.
- Redness Reduction: The combination helps reduce redness and inflammation in the eyes, providing relief from discomfort caused by the dilation of blood vessels in the conjunctiva.
There are certain conditions and situations where the combination of Pheniramine Maleate + Naphazoline HCl should not be used:
- Hypersensitivity: This product is contraindicated in patients who are allergic to Pheniramine Maleate, Naphazoline, or any of the excipients in the formulation.
- Narrow-Angle Glaucoma: Patients with narrow-angle glaucoma should avoid this medication as Naphazoline can increase intraocular pressure, which may exacerbate the condition.
- Severe Cardiovascular Disorders: Patients with certain cardiovascular diseases, such as hypertension or arrhythmias, should avoid using this combination, as Naphazoline (a sympathomimetic) can elevate blood pressure.
- Children under 6 years of age: This combination is generally not recommended for use in young children due to the risk of systemic side effects from the decongestant component, Naphazoline.
Pheniramine Maleate + Naphazoline HCl eye drops are generally well tolerated, but they can cause some side effects, including:
- Common Side Effects:
- Eye irritation or a burning sensation immediately after application.
- Redness or temporary blurring of vision.
- Dryness or itching in the eyes.
- Pupil dilation in some cases, especially if the drops are overused.
- Serious Side Effects (requiring medical attention):
- Allergic reactions: Symptoms may include swelling of the eyelids, face, or throat, rash, and difficulty breathing.
- Increased intraocular pressure, especially in individuals with glaucoma, leading to headaches, eye pain, and blurred vision.
- Systemic effects: If absorbed into the bloodstream, Naphazoline can cause elevated blood pressure, headaches, tachycardia, or nervousness.
- Prolonged or excessive use may lead to rebound congestion, where the eye redness becomes worse after stopping the drops.
Patients should contact their healthcare provider if they experience persistent side effects or if any severe reactions occur.
3
- Pheniramine Maleate: As an antihistamine, Pheniramine works by blocking histamine receptors (H1 receptors) in the eyes, which are responsible for causing allergic reactions. This helps reduce itching, swelling, and redness caused by allergens.
- Naphazoline HCl: Naphazoline is a sympathomimetic decongestant that works by constricting the blood vessels in the conjunctiva (the thin membrane covering the white part of the eye). This leads to a reduction in redness and swelling of the eyes. It achieves this effect by stimulating alpha-adrenergic receptors, causing vasoconstriction.
The combination of these two agents works synergistically to alleviate symptoms of allergic conjunctivitis and other forms of eye irritation by both reducing the allergic response and constricting dilated blood vessels in the eyes.
Several drug interactions could occur when using Pheniramine Maleate + Naphazoline HCl eye drops:
- Other Antihistamines: Concurrent use with oral antihistamines may increase the risk of sedation and other central nervous system effects. Patients should be cautious when combining antihistamines.
- Sympathomimetic Drugs: Naphazoline is a sympathomimetic drug, and its use with other drugs that increase sympathetic tone (e.g., adrenaline, dopamine, or certain nasal decongestants) could lead to elevated blood pressure or tachycardia.
- MAO Inhibitors: When combined with monoamine oxidase inhibitors (MAOIs), the sympathomimetic effects of Naphazoline may be exaggerated, leading to severe hypertension or other cardiovascular issues.
- Other Eye Preparations: Patients using other eye drops or ointments should wait at least 5 minutes before applying additional products to avoid dilution or interference with the therapeutic effects of the eye preparation.
- The usual adult dose of Pheniramine Maleate + Naphazoline HCl eye preparation is to apply 1-2 drops in the affected eye(s) up to 3-4 times daily or as directed by a healthcare provider.
- If symptoms persist after several days, it is recommended to consult a healthcare provider for further evaluation, as prolonged use may not be advised.
This combination is typically not recommended for children under 6 years of age due to the potential risks associated with Naphazoline. For children over 6, the dose is usually 1 drop in the affected eye(s) up to 3-4 times daily, but it is crucial to follow a healthcare provider’s recommendations for pediatric use.
Patients must always consult their healthcare provider before using Pheniramine Maleate + Naphazoline HCl to ensure its safety and appropriateness for their condition.
There is no specific renal dose adjustment for Pheniramine Maleate + Naphazoline HCl eye preparation because it is used topically and has minimal systemic absorption. However, patients with severe renal impairment should still consult a healthcare provider, as individual responses may vary.
Not available in a medicine form yet